ArticleNature biotechnology2017
Making individualized drugs a reality.
Article in Nature biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- From precision interventions to precision health.Nature communications · 2025Review
- On-demand biomanufacturing through synthetic biology approach.Materials today. Bio · 2023Article
- Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.Orphanet journal of rare diseases · 2022Article
- We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis.Health and human rights · 2021Article
- Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics.Pharmaceutical research · 2021Review
- Strategies for Testing Intervention Matching Schemes in Cancer.Clinical pharmacology and therapeutics · 2020Review
- Versatile biomanufacturing through stimulus-responsive cell-material feedback.Nature chemical biology · 2019Article
- Magistral drug production in Colombia and other middle-income countries.Nature biotechnology · 2019Article
- Artificial Intelligence and Personalized Medicine.Cancer treatment and research · 2019Article
- On-demand manufacturing of clinical-quality biopharmaceuticals.Nature biotechnology · 2018Article
- Rapid recombinant protein expression in cell-free extracts from human blood.Scientific reports · 2018Article
- A perspective on multi-target drug discovery and design for complex diseases.Clinical and translational medicine · 2018Article
- Compounded medication for patients with rare diseases.Orphanet journal of rare diseases · 2018Review
- Erratum: Making individualized drugs a reality.Nature biotechnology · 2017Article
- Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.Journal of drug targetingReview
- Article
Corrections and comments
- Commented on by
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
28581491What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.